UK's Roebuck Food H1 operating loss widens
UK's Roebuck Food H1 operating loss widens
Overview
UK food ingredients and agri-tech investor's H1 revenue rose 7% yr/yr
Operating loss widened on higher admin expenses and GlasPort Bio investment
CEO transition announced, with GlasPort Bio CEO to become group CEO in October
Outlook
GlasPort Bio expects 40-45 additional installations in H2 2026 across Ireland and Europe
Company says ramping up GlasPort installs will increase cash burn in H2 2026
Further measures to release capital from Plant-based Ingredient Division are well advanced for H2 2026
Result Drivers
PLANT-BASED DIVISION RECOVERY - Moorhead & McGavin returned to profitability after restructuring, cost reductions, and improved sales and gross margins
GLASPORT BIO REVENUE - GlasPort Bio generated revenue for the first time after GasAbate system installations, but losses widened due to higher admin expenses, lower grant income, and increased R&D investment
FORO PROFITABILITY - Foro's profitability improved despite lower sales, driven by a better mix of higher-margin business
Company press release: ID:nRSd9645Wa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue |
| GBP 5.5 mln |
|
H1 EBIT |
| -GBP 1.3 mln |
|
H1 Gross Profit |
| GBP 819,000 |
|
Analyst Coverage
The stock recently traded at 311 times the next 12-month earnings vs. a P/E of 324 three months ago
Reuters Recommended Reads
Sept 29 - UK's A G Barr interim revenue rises 8.5% on core brands and acquisitions
Sept 30 - UK's Shepherd Neame FY revenue slips, partly on fall in beer volumes
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)